[IQC结果的长期自动化贝叶斯管理:里昂医院委员会止血实验室的经验]。

IF 0.4 4区医学 Q4 MEDICAL LABORATORY TECHNOLOGY Annales de biologie clinique Pub Date : 2023-05-16 DOI:10.1684/abc.2023.1800

Frédéric Sobas, Émilie Jousselme, Marie-Odile Geay Baillat, Estelle Cheli, Amy Dericquebourg, Christophe Nougier

{"title":"[IQC结果的长期自动化贝叶斯管理:里昂医院委员会止血实验室的经验]。","authors":"Frédéric Sobas, Émilie Jousselme, Marie-Odile Geay Baillat, Estelle Cheli, Amy Dericquebourg, Christophe Nougier","doi":"10.1684/abc.2023.1800","DOIUrl":null,"url":null,"abstract":"The Lyon Hospitals Board (HCL) hemostasis laboratory has shifted from a frequentist to a long-term Bayesian approach to IQC results management, using the Hemohub® software of the Werfen corporation, which hosts the requisite Bayesian tools. IQC plans based on supplier specifications proved effective in managing analytic risk in line with the ISO 15189 standard. Long-term Hemohub® control and monitoring has been validated by acceptable feedback from the EQA organization used by the hemostasis community.","PeriodicalId":7892,"journal":{"name":"Annales de biologie clinique","volume":"81 2","pages":"181-188"},"PeriodicalIF":0.4000,"publicationDate":"2023-05-16","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"[Long-term automated Bayesian management of IQC results: The experience of the Lyon Hospitals Board hemostasis laboratory].\",\"authors\":\"Frédéric Sobas, Émilie Jousselme, Marie-Odile Geay Baillat, Estelle Cheli, Amy Dericquebourg, Christophe Nougier\",\"doi\":\"10.1684/abc.2023.1800\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"The Lyon Hospitals Board (HCL) hemostasis laboratory has shifted from a frequentist to a long-term Bayesian approach to IQC results management, using the Hemohub® software of the Werfen corporation, which hosts the requisite Bayesian tools. IQC plans based on supplier specifications proved effective in managing analytic risk in line with the ISO 15189 standard. Long-term Hemohub® control and monitoring has been validated by acceptable feedback from the EQA organization used by the hemostasis community.\",\"PeriodicalId\":7892,\"journal\":{\"name\":\"Annales de biologie clinique\",\"volume\":\"81 2\",\"pages\":\"181-188\"},\"PeriodicalIF\":0.4000,\"publicationDate\":\"2023-05-16\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Annales de biologie clinique\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.1684/abc.2023.1800\",\"RegionNum\":4,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q4\",\"JCRName\":\"MEDICAL LABORATORY TECHNOLOGY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Annales de biologie clinique","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1684/abc.2023.1800","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"MEDICAL LABORATORY TECHNOLOGY","Score":null,"Total":0}

引用次数: 0

摘要

里昂医院委员会(HCL)止血实验室已经从频率学家转变为长期的贝叶斯方法来进行IQC结果管理，使用Werfen公司的haemhub®软件，该软件拥有必要的贝叶斯工具。基于供应商规范的IQC计划在管理分析风险方面被证明是有效的，符合ISO 15189标准。长期的haemhub®控制和监测已通过止血社区使用的EQA组织的可接受反馈进行验证。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

查看原文

微信好友朋友圈 QQ好友复制链接

本刊更多论文

[Long-term automated Bayesian management of IQC results: The experience of the Lyon Hospitals Board hemostasis laboratory].

The Lyon Hospitals Board (HCL) hemostasis laboratory has shifted from a frequentist to a long-term Bayesian approach to IQC results management, using the Hemohub® software of the Werfen corporation, which hosts the requisite Bayesian tools. IQC plans based on supplier specifications proved effective in managing analytic risk in line with the ISO 15189 standard. Long-term Hemohub® control and monitoring has been validated by acceptable feedback from the EQA organization used by the hemostasis community.

求助全文

通过发布文献求助，成功后即可免费获取论文全文。去求助

来源期刊

Annales de biologie clinique 医学-医学：研究与实验

CiteScore

0.80

自引率

20.00%

发文量

审稿时长

6-12 weeks

期刊介绍： Multidisciplinary information with direct relevance to everyday practice Annales de Biologie Clinique, the official journal of the French Society of Clinical Biology (SFBC), supports biologists in areas including continuing education, laboratory accreditation and technique validation. With original articles, abstracts and accounts of everyday practice, the journal provides details of advances in knowledge, techniques and equipment, as well as a forum for discussion open to the entire community.